Works matching IS 03407004 AND DT 2021 AND VI 70 AND IP 5

Results: 27

Correction to: In vitro and in vivo evaluation of anti‑tumoral effect of M1 phenotype induction in macrophages by miR‑130 and miR‑33 containing exosomes.

Published in:

2021

By:

Moradi-Chaleshtori, Maryam;
Bandehpour, Mojgan;
Soudi, Sara;
Mohammadi-Yeganeh, Samira;
Hashemi, Seyed Mahmoud

Publication type:

Correction Notice

Modeling of tumor response to macrophage and T lymphocyte interactions in the liver metastatic microenvironment.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 5, p. 1475, doi. 10.1007/s00262-020-02785-4

By:

Curtis, Louis T.;
Sebens, Susanne;
Frieboes, Hermann B.

Publication type:

Article

Correction to: Modeling of tumor response to macrophage and T lymphocyte interactions in the liver metastatic microenvironment.

Published in:

2021

By:

Curtis, Louis T.;
Sebens, Susanne;
Frieboes, Hermann B.

Publication type:

Correction Notice

Prognostic significance of PD-1/PD-L1 expression in uveal melanoma: correlation with tumor-infiltrating lymphocytes and clinicopathological parameters.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 5, p. 1291, doi. 10.1007/s00262-020-02773-8

By:

Singh, Lata;
Singh, Mithalesh Kumar;
Kenney, Maria Cristina;
Jager, Martine J.;
Rizvi, Moshahid Alam;
Meel, Rachna;
Lomi, Neiwete;
Bakhshi, Sameer;
Sen, Seema;
Kashyap, Seema

Publication type:

Article

B7-H3 confers resistance to Vγ9Vδ2 T cell-mediated cytotoxicity in human colon cancer cells via the STAT3/ULBP2 axis.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 5, p. 1213, doi. 10.1007/s00262-020-02771-w

By:

Lu, Huimin;
Ma, Yanchao;
Wang, Mingyuan;
Shen, Jin;
Wu, Hongya;
Li, Juntao;
Gao, Nan;
Gu, Yanzheng;
Zhang, Xueguang;
Zhang, Guangbo;
Shi, Tongguo;
Chen, Weichang

Publication type:

Article

Correlation of tumor microenvironment from biopsy and resection specimens in untreated colorectal cancer patients: a surprising lack of agreement.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 5, p. 1465, doi. 10.1007/s00262-020-02784-5

By:

Kemp Bohan, Phillip M.;
Chick, Robert C.;
Hickerson, Annelies T.;
Messersmith, Lynn M.;
Williams, Grant M.;
Cindass, Jessica L.;
Lombardo, Jamie;
Collins, Ryan;
Brady, Robert O.;
Hale, Diane F.;
Peoples, George E.;
Vreeland, Timothy J.;
Clifton, Guy T.

Publication type:

Article

Prognostic significance of S100A8-positive immune cells in relation to other immune cell infiltration in pre-invasive and invasive breast cancers.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 5, p. 1365, doi. 10.1007/s00262-020-02776-5

By:

Woo, Ji Won;
Chung, Yul Ri;
Kim, Milim;
Choi, Hye Yeon;
Ahn, Soomin;
Park, So Yeon

Publication type:

Article

Combination of novel intravesical xenogeneic urothelial cell immunotherapy and chemotherapy enhances anti-tumor efficacy in preclinical murine bladder tumor models.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 5, p. 1419, doi. 10.1007/s00262-020-02775-6

By:

Huang, Chi-Ping;
Wu, Chun-Chie;
Shyr, Chih-Rong

Publication type:

Article

Telomerase-specific oncolytic immunotherapy for promoting efficacy of PD-1 blockade in osteosarcoma.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 5, p. 1405, doi. 10.1007/s00262-020-02774-7

By:

Mochizuki, Yusuke;
Tazawa, Hiroshi;
Demiya, Koji;
Kure, Miho;
Kondo, Hiroya;
Komatsubara, Tadashi;
Sugiu, Kazuhisa;
Hasei, Joe;
Yoshida, Aki;
Kunisada, Toshiyuki;
Urata, Yasuo;
Kagawa, Shunsuke;
Ozaki, Toshifumi;
Fujiwara, Toshiyoshi

Publication type:

Article

The M1/M2 spectrum and plasticity of malignant pleural effusion-macrophage in advanced lung cancer.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 5, p. 1435, doi. 10.1007/s00262-020-02781-8

By:

Wu, Ming-Fang;
Lin, Chih-An;
Yuan, Tzu-Hang;
Yeh, Hsiang-Yuan;
Su, Sheng-Fang;
Guo, Chin-Lin;
Chang, Gee-Chen;
Li, Ker-Chau;
Ho, Chao-Chi;
Chen, Huei-Wen

Publication type:

Article

IL-10, IL-13, Eotaxin and IL-10/IL-6 ratio distinguish breast implant-associated anaplastic large-cell lymphoma from all types of benign late seromas.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 5, p. 1379, doi. 10.1007/s00262-020-02778-3

By:

Di Napoli, Arianna;
Greco, Daniele;
Scafetta, Giorgia;
Ascenzi, Francesca;
Gulino, Alessandro;
Aurisicchio, Luigi;
Santanelli Di Pompeo, Fabio;
Bonifacino, Adriana;
Giarnieri, Enrico;
Morgan, John;
Mancini, Rita;
Kadin, Marshall E.

Publication type:

Article

Nicotine exhausts CD8+ T cells against tumor cells through increasing miR-629-5p to repress IL2RB-mediated granzyme B expression.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 5, p. 1351, doi. 10.1007/s00262-020-02770-x

By:

Cheng, Chun-Chia;
Lin, Hsin-Chi;
Chiang, Ya-Wen;
Chang, Jungshan;
Sie, Zong-Lin;
Yang, Bi-Ling;
Lim, Ken-Hong;
Peng, Cheng-Liang;
Ho, Ai-Sheng;
Chang, Yi-Fang

Publication type:

Article

SAKK 19/17: safety analysis of first-line durvalumab in patients with PD-L1 positive, advanced nonsmall cell lung cancer and a performance status of 2.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 5, p. 1255, doi. 10.1007/s00262-020-02757-8

By:

Mark, Michael;
Froesch, Patrizia;
Eboulet, Eric Innocents;
Addeo, Alfredo;
Pless, Miklos;
Rothschild, Sacha I.;
Janthur, Wolf-Dieter;
Burmeister, Henning;
Friedlaender, Alex;
Schneider, Martina;
Metaxas, Yannis;
Joerger, Markus;
Wannesson, Luciano;
Schwitter, Michael;
Baudoux, Nathalie;
Weindler, Susanne;
Biaggi-Rudolf, Christine;
Früh, Martin

Publication type:

Article

The role of dendritic cells for therapy of B-cell lymphoma with immune checkpoint inhibitors.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 5, p. 1343, doi. 10.1007/s00262-020-02767-6

By:

Scheuerpflug, Anne;
Ahmetlić, Fatima;
Bauer, Vera;
Riedel, Tanja;
Röcken, Martin;
Mocikat, Ralph

Publication type:

Article

Immunotherapy in nonsmall-cell lung cancer: current status and future prospects for liquid biopsy.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 5, p. 1177, doi. 10.1007/s00262-020-02752-z

By:

Brozos-Vázquez, Elena María;
Díaz-Peña, Roberto;
García-González, Jorge;
León-Mateos, Luis;
Mondelo-Macía, Patricia;
Peña-Chilet, María;
López-López, Rafael

Publication type:

Article

Impact of tumor heterogeneity and microenvironment in identifying neoantigens in a patient with ovarian cancer.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 5, p. 1189, doi. 10.1007/s00262-020-02764-9

By:

Dao, Tao;
Klatt, Martin G.;
Korontsvit, Tatyana;
Mun, Sung Soo;
Guzman, Sean;
Mattar, Marissa;
Zivanovic, Oliver;
Kyi, Chrisann K.;
Socci, Nicholas D.;
O'Cearbhaill, Roisin E.;
Scheinberg, David A.

Publication type:

Article

In vitro and in vivo evaluation of anti-tumoral effect of M1 phenotype induction in macrophages by miR-130 and miR-33 containing exosomes.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 5, p. 1323, doi. 10.1007/s00262-020-02762-x

By:

Moradi-Chaleshtori, Maryam;
Bandehpour, Mojgan;
Soudi, Sara;
Mohammadi-Yeganeh, Samira;
Hashemi, Seyed Mahmoud

Publication type:

Article

Noninvasive, longitudinal imaging-based analysis of body adipose tissue and water composition in a melanoma mouse model and in immune checkpoint inhibitor-treated metastatic melanoma patients.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 5, p. 1263, doi. 10.1007/s00262-020-02765-8

By:

Thaiss, Wolfgang M.;
Gatidis, Sergios;
Sartorius, Tina;
Machann, Jürgen;
Peter, Andreas;
Eigentler, Thomas K.;
Nikolaou, Konstantin;
Pichler, Bernd J.;
Kneilling, Manfred

Publication type:

Article

Nivolumab for esophageal squamous cell carcinoma and the predictive role of PD-L1 or CD8 expression in its therapeutic effect.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 5, p. 1203, doi. 10.1007/s00262-020-02766-7

By:

Lee, Jiyun;
Kim, Binnari;
Jung, Hyun Ae;
La Choi, Yoon;
Sun, Jong-Mu

Publication type:

Article

Low-dose ipilimumab plus nivolumab combined with IL-2 and hyperthermia in cancer patients with advanced disease: exploratory findings of a case series of 131 stage IV cancers – a retrospective study of a single institution.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 5, p. 1393, doi. 10.1007/s00262-020-02751-0

By:

Kleef, R.;
Nagy, R.;
Baierl, A.;
Bacher, V.;
Bojar, H.;
McKee, D. L.;
Moss, R.;
Thoennissen, N. H.;
Szász, M.;
Bakacs, T.

Publication type:

Article

Granzyme B in peripheral blood mononuclear cells as a measure of cell-mediated immune response in paraneoplastic neurological syndromes and malignancy.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 5, p. 1277, doi. 10.1007/s00262-020-02750-1

By:

Zaborowski, Mikołaj Piotr;
Stefens-Stawna, Patrycja;
Osztynowicz, Krystyna;
Piorunek, Tomasz;
Batura-Gabryel, Halina;
Dyzmann-Sroka, Agnieszka;
Kozubski, Wojciech;
Nowak-Markwitz, Ewa;
Michalak, Sławomir

Publication type:

Article

IL-15 superagonist N-803 improves IFNγ production and killing of leukemia and ovarian cancer cells by CD34+ progenitor-derived NK cells.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 5, p. 1305, doi. 10.1007/s00262-020-02749-8

By:

Van der Meer, J. M. R.;
Maas, R. J. A.;
Guldevall, K.;
Klarenaar, K.;
de Jonge, P. K. J. D.;
Evert, J. S. Hoogstad-van;
van der Waart, A. B.;
Cany, J.;
Safrit, J. T.;
Lee, J. H.;
Wagena, E.;
Friedl, P.;
Önfelt, B.;
Massuger, L. F.;
Schaap, N. P. M.;
Jansen, J. H.;
Hobo, W.;
Dolstra, H.

Publication type:

Article

Characterization of the tumor immune microenvironment in human papillomavirus-positive and -negative head and neck squamous cell carcinomas.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 5, p. 1227, doi. 10.1007/s00262-020-02747-w

By:

Succaria, Farah;
Kvistborg, Pia;
Stein, Julie E.;
Engle, Elizabeth L.;
McMiller, Tracee L.;
Rooper, Lisa M.;
Thompson, Elizabeth;
Berger, Alan E.;
van den Brekel, Michiel;
Zuur, Charlotte L.;
Haanen, John;
Topalian, Suzanne L.;
Taube, Janis M.

Publication type:

Article

Induction of cytotoxic effector cells towards cholangiocellular, pancreatic, and colorectal tumor cells by activation of the immune checkpoint CD40/CD40L on dendritic cells.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 5, p. 1451, doi. 10.1007/s00262-020-02746-x

By:

Sadeghlar, Farsaneh;
Vogt, Annabelle;
Mohr, Raphael U.;
Mahn, Robert;
van Beekum, Katrin;
Kornek, Miroslaw;
Weismüller, Tobias J.;
Branchi, Vittorio;
Matthaei, Hanno;
Toma, Marieta;
Schmidt-Wolf, I. G. H.;
Kalff, Jörg C.;
Strassburg, Christian P.;
González-Carmona, Maria A.

Publication type:

Article

CD1d expression in glioblastoma is a promising target for NKT cell-based cancer immunotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 5, p. 1239, doi. 10.1007/s00262-020-02742-1

By:

Hara, Ayaka;
Koyama-Nasu, Ryo;
Takami, Mariko;
Toyoda, Takahide;
Aoki, Takahiro;
Ihara, Fumie;
Kobayashi, Masayoshi;
Hirono, Seiichiro;
Matsutani, Tomoo;
Nakayama, Toshinori;
Iwadate, Yasuo;
Motohashi, Shinichiro

Publication type:

Article

Stress relief for cancer immunotherapy: implications for the ER stress response in tumor immunity.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 5, p. 1165, doi. 10.1007/s00262-020-02740-3

By:

Andrews, Alex M.;
Tennant, Megan D.;
Thaxton, Jessica E.

Publication type:

Article

Hyperprogressive disease rarely occurs during checkpoint inhibitor treatment for advanced melanoma.

Published in:

Cancer Immunology, Immunotherapy, 2021, v. 70, n. 5, p. 1491, doi. 10.1007/s00262-020-02716-3

By:

Schuiveling, M.;
Tonk, E. H. J.;
Verheijden, R. J.;
Suijkerbuijk, K. P. M.

Publication type:

Article